Federal Register notice: FDA requests that any consumer organizations interested in participating in selecting voting or nonvoting consumer representa...
Federal Register notice: FDA announces a 2/24 public meeting on FDA Rare Disease Day 2020: Supporting the Future of Rare Disease Product Development....
Federal Register notice: FDA seeks comments on a new information collection entitled Empirical Study of Promotional Implications of Proprietary Prescr...
FDA Review has posted the Federal Register notices for the week ending 1/17/2020.
FDA Review posts product approval summaries for the week ending 1/18/2020.
FDA approves a new indication for Novo Nordisks Ozempic (semaglutide) injection 0.5 mg or 1 mg reducing the risk of major adverse cardiovascular even...
FDA seeks comments on new proposed research by CDERs Office of Prescription Drug Promotion on promotional implications of proprietary drug names.
FDAs Anesthetic and Analgesic Drug Products Advisory Committee issues a split vote (6 to 6) on the approval of Durect Corp.s surgical pain drug Posimi...